Case-only analysis investigating prescription (ATC) history during the vaccination period and before index date and diagnosis (ICD10) history before index date on risk of developing narcolepsy.

Case-centered analysis results of Guillain-Barré syndrome (GBS) with prior vaccination and with prior infection, Vaccine Safety Datalink, 2009–2011.

Sharon K. Greene (427152)
Melisa D. Rett (368699)
Claudia Vellozzi (427153)
Lingling Li (427154)
Martin Kulldorff (57938)
S. Michael Marcy (427155)
Matthew F. Daley (427156)
Edward A. Belongia (209731)
Roger Baxter (427157)
Bruce H. Fireman (427158)
Michael L. Jackson (411527)
Saad B. Omer (199402)
James D. Nordin (427159)
Robert Jin (427160)
Eric S. Weintraub (427161)
Vinutha Vijayadeva (427162)
Grace M. Lee (427163)

June 2013

aAdjusted for GBS onset date, age group, sex, site, and medically-attended infection status in 1 ...

Retrospective multicenter matched case–control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany

Oberle, Doris
Pavel, Jutta
Mayer, Geert
Geisler, Peter
Keller-Stanislawski, Brigitte

January 2017

Objective: Studies associate pandemic influenza vaccination with narcolepsy. In Germany, a retrospec...

Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers

남궁기
이은

January 2015

BACKGROUND: Previous reports mostly from Europe suggested an association between an occurrence of na...

Risk of narcolepsy ± narcolepsy associated with A/H1N1 (2009) vaccination using the cohort method according to observation period and post-vaccination risk period, in Quebec, 2009–2010.

Jacques Montplaisir (213883)
Dominique Petit (636102)
Marie-Josée Quinn (636103)
Manale Ouakki (317022)
Geneviève Deceuninck (296798)
Alex Desautels (282040)
Emmanuel Mignot (31065)
Philippe De Wals (296811)

September 2014

+: Cases with onset after vaccination during risk period; E−: Cases not vaccinated or with ons...

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination

Lamb, F. (Favelle)
Ploner, Alexander
Fink, K. (Katharina)
Maeurer, M. (Markus)
Bergman, P. (Peter)
Piehl, Fredrik
Weibel, Daniel
Sparen, Pär
Dahlström, Lisen Arnheim

January 2016

textabstractOBJECTIVES: To investigate disease history before A(H1N1)pdm09 vaccination as a risk fac...

Exposure windows.

Favelle Lamb (2633683)
Alexander Ploner (23549)
Katharina Fink (494285)
Markus Maeurer (299545)
Peter Bergman (218605)
Fredrik Piehl (155191)
Daniel Weibel (505597)
Pär Sparén (255802)
Lisen Arnheim Dahlström (350408)

April 2016

1. Prescription (ATC) and diagnosis (ICD10) history before index date (MSLT-referral date). Ever ...

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination.

Favelle Lamb
Alexander Ploner
Katharina Fink
Markus Maeurer
Peter Bergman
Fredrik Piehl
Daniel Weibel
Pär Sparén
Lisen Arnheim Dahlström

OBJECTIVES:To investigate disease history before A(H1N1)pdm09 vaccination as a risk factor for narco...

Risk of narcolepsy ± narcolepsy associated with A/H1N1 (2009) vaccination using the ‘self-controlled case-series method’ according to age and diagnostic classification, in the province of Quebec, 2009–2010.

Jacques Montplaisir (213883)
Dominique Petit (636102)
Marie-Josée Quinn (636103)
Manale Ouakki (317022)
Geneviève Deceuninck (296798)
Alex Desautels (282040)
Emmanuel Mignot (31065)
Philippe De Wals (296811)

September 2014

Risk of narcolepsy ± narcolepsy associated with A/H1N1 (2009) vaccination using the ‘self-control...

The different time intervals from the vaccination to the onset of narcolepsy depending on the definition of the onset time point, i.e. a) estimated onset time based on the extensive review of the patient records by a sleep and/or narcolepsy specialist, and closest to the parental/patient recall; b) first recorded contact to health care because of excessive sleepiness; c) date of referral to paediatrician or pediatric neurologist; and d) date of setting the diagnosis of narcolepsy, ICD-10 G47.4.

Hanna Nohynek (328056)
Jukka Jokinen (328057)
Markku Partinen (175013)
Outi Vaarala (328058)
Turkka Kirjavainen (175086)
Jonas Sundman (328059)
Sari-Leena Himanen (328060)
Christer Hublin (175027)
Ilkka Julkunen (175083)
Päivi Olsén (175037)
Outi Saarenpää-Heikkilä (175017)
Terhi Kilpi (328062)

February 2013

The different time intervals from the vaccination to the onset of narcolepsy depending on the def...

Sensitivity analyses of the risk ratio of Pandemrix vaccination and narcolepsy using different definitions of the onset dates of narcolepsy and follow-up time periods.

Hanna Nohynek (328056)
Jukka Jokinen (328057)
Markku Partinen (175013)
Outi Vaarala (328058)
Turkka Kirjavainen (175086)
Jonas Sundman (328059)
Sari-Leena Himanen (328060)
Christer Hublin (175027)
Ilkka Julkunen (175083)
Päivi Olsén (175037)
Outi Saarenpää-Heikkilä (175017)
Terhi Kilpi (328062)

February 2013

The two intervals in the top left panel are missing because of infinite estimates (i.e. no cases ...

Association Between Adverse Events of Special Interest and Pandemic (H1N1) 2009 Monovalent Vaccine Without Adjuvant, by Age Group and Risk Interval, November 1, 2009–February 28, 2010.

Wan-Ting Huang (210819)
Hsu-Wen Yang (387741)
Tzu-Lin Liao (387742)
Wan-Jen Wu (387743)
Shu-Er Yang (387744)
Yi-Chien Chih (387745)
Jen-Hsiang Chuang (210836)

March 2013

Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...

Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.

Julia Stowe
Nick Andrews
Paul Gringras
Timothy Quinnell
Zenobia Zaiwalla
John Shneerson
Elizabeth Miller

September 2020

BackgroundEarly studies of narcolepsy after AS03-adjuvanted pandemic A/H1N12009 vaccine (Pandemrix) ...

Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in Quebec

Jacques Montplaisir (213883)
Dominique Petit (636102)
Marie-Josée Quinn (636103)
Manale Ouakki (317022)
Geneviève Deceuninck (296798)
Alex Desautels (282040)
Emmanuel Mignot (31065)
Philippe De Wals (296811)

September 2014

<div>ContextAn association between an adjuvanted (AS03) A/H1N1 pandemic vaccine and narcol...

Respiratory Infections and Risk for Development of Narcolepsy: Analysis of the Truven Health MarketScan Database (2008 to 2010) with Additional Assessment of Incidence and Prevalence

Scheer, Darren

March 2019

Background and Significance: Narcolepsy is a chronic neurological disorder. These patients experie...

Sub-group analysis comparing CV-disease incidence in patients with vs. without insomnia based on length of follow-up period.

Eman Ali (7497833)
Asim Shaikh (17020701)
Farah Yasmin (11744603)
Fatima Sughra (17020704)
Ayesha Sheikh (17020707)
Rabia Owais (17020710)
Hamna Raheel (17020713)
Hafeez Ul Hassan Virk (10743664)
Jihad A. Mustapha (9085634)

September 2023

Sub-group analysis comparing CV-disease incidence in patients with vs. without insomnia based on len...

Case-centered analysis results of Guillain-Barré syndrome (GBS) with prior vaccination and with prior infection, Vaccine Safety Datalink, 2009–2011.

Sharon K. Greene (427152)
Melisa D. Rett (368699)
Claudia Vellozzi (427153)
Lingling Li (427154)
Martin Kulldorff (57938)
S. Michael Marcy (427155)
Matthew F. Daley (427156)
Edward A. Belongia (209731)
Roger Baxter (427157)
Bruce H. Fireman (427158)
Michael L. Jackson (411527)
Saad B. Omer (199402)
James D. Nordin (427159)
Robert Jin (427160)
Eric S. Weintraub (427161)
Vinutha Vijayadeva (427162)
Grace M. Lee (427163)

June 2013

aAdjusted for GBS onset date, age group, sex, site, and medically-attended infection status in 1 ...

Retrospective multicenter matched case–control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany

Oberle, Doris
Pavel, Jutta
Mayer, Geert
Geisler, Peter
Keller-Stanislawski, Brigitte

January 2017

Objective: Studies associate pandemic influenza vaccination with narcolepsy. In Germany, a retrospec...

Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers

남궁기
이은

January 2015

BACKGROUND: Previous reports mostly from Europe suggested an association between an occurrence of na...

Risk of narcolepsy ± narcolepsy associated with A/H1N1 (2009) vaccination using the cohort method according to observation period and post-vaccination risk period, in Quebec, 2009–2010.

Jacques Montplaisir (213883)
Dominique Petit (636102)
Marie-Josée Quinn (636103)
Manale Ouakki (317022)
Geneviève Deceuninck (296798)
Alex Desautels (282040)
Emmanuel Mignot (31065)
Philippe De Wals (296811)

September 2014

+: Cases with onset after vaccination during risk period; E−: Cases not vaccinated or with ons...

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination

Lamb, F. (Favelle)
Ploner, Alexander
Fink, K. (Katharina)
Maeurer, M. (Markus)
Bergman, P. (Peter)
Piehl, Fredrik
Weibel, Daniel
Sparen, Pär
Dahlström, Lisen Arnheim

January 2016

textabstractOBJECTIVES: To investigate disease history before A(H1N1)pdm09 vaccination as a risk fac...

Exposure windows.

Favelle Lamb (2633683)
Alexander Ploner (23549)
Katharina Fink (494285)
Markus Maeurer (299545)
Peter Bergman (218605)
Fredrik Piehl (155191)
Daniel Weibel (505597)
Pär Sparén (255802)
Lisen Arnheim Dahlström (350408)

April 2016

1. Prescription (ATC) and diagnosis (ICD10) history before index date (MSLT-referral date). Ever ...

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination.

Favelle Lamb
Alexander Ploner
Katharina Fink
Markus Maeurer
Peter Bergman
Fredrik Piehl
Daniel Weibel
Pär Sparén
Lisen Arnheim Dahlström

OBJECTIVES:To investigate disease history before A(H1N1)pdm09 vaccination as a risk factor for narco...

Risk of narcolepsy ± narcolepsy associated with A/H1N1 (2009) vaccination using the ‘self-controlled case-series method’ according to age and diagnostic classification, in the province of Quebec, 2009–2010.

Jacques Montplaisir (213883)
Dominique Petit (636102)
Marie-Josée Quinn (636103)
Manale Ouakki (317022)
Geneviève Deceuninck (296798)
Alex Desautels (282040)
Emmanuel Mignot (31065)
Philippe De Wals (296811)

September 2014

Risk of narcolepsy ± narcolepsy associated with A/H1N1 (2009) vaccination using the ‘self-control...

The different time intervals from the vaccination to the onset of narcolepsy depending on the definition of the onset time point, i.e. a) estimated onset time based on the extensive review of the patient records by a sleep and/or narcolepsy specialist, and closest to the parental/patient recall; b) first recorded contact to health care because of excessive sleepiness; c) date of referral to paediatrician or pediatric neurologist; and d) date of setting the diagnosis of narcolepsy, ICD-10 G47.4.

Hanna Nohynek (328056)
Jukka Jokinen (328057)
Markku Partinen (175013)
Outi Vaarala (328058)
Turkka Kirjavainen (175086)
Jonas Sundman (328059)
Sari-Leena Himanen (328060)
Christer Hublin (175027)
Ilkka Julkunen (175083)
Päivi Olsén (175037)
Outi Saarenpää-Heikkilä (175017)
Terhi Kilpi (328062)

February 2013

The different time intervals from the vaccination to the onset of narcolepsy depending on the def...

Sensitivity analyses of the risk ratio of Pandemrix vaccination and narcolepsy using different definitions of the onset dates of narcolepsy and follow-up time periods.

Hanna Nohynek (328056)
Jukka Jokinen (328057)
Markku Partinen (175013)
Outi Vaarala (328058)
Turkka Kirjavainen (175086)
Jonas Sundman (328059)
Sari-Leena Himanen (328060)
Christer Hublin (175027)
Ilkka Julkunen (175083)
Päivi Olsén (175037)
Outi Saarenpää-Heikkilä (175017)
Terhi Kilpi (328062)

February 2013

The two intervals in the top left panel are missing because of infinite estimates (i.e. no cases ...

Association Between Adverse Events of Special Interest and Pandemic (H1N1) 2009 Monovalent Vaccine Without Adjuvant, by Age Group and Risk Interval, November 1, 2009–February 28, 2010.

Wan-Ting Huang (210819)
Hsu-Wen Yang (387741)
Tzu-Lin Liao (387742)
Wan-Jen Wu (387743)
Shu-Er Yang (387744)
Yi-Chien Chih (387745)
Jen-Hsiang Chuang (210836)

March 2013

Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...

Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.

Julia Stowe
Nick Andrews
Paul Gringras
Timothy Quinnell
Zenobia Zaiwalla
John Shneerson
Elizabeth Miller

September 2020

BackgroundEarly studies of narcolepsy after AS03-adjuvanted pandemic A/H1N12009 vaccine (Pandemrix) ...

Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in Quebec

Jacques Montplaisir (213883)
Dominique Petit (636102)
Marie-Josée Quinn (636103)
Manale Ouakki (317022)
Geneviève Deceuninck (296798)
Alex Desautels (282040)
Emmanuel Mignot (31065)
Philippe De Wals (296811)

September 2014

<div>ContextAn association between an adjuvanted (AS03) A/H1N1 pandemic vaccine and narcol...

Respiratory Infections and Risk for Development of Narcolepsy: Analysis of the Truven Health MarketScan Database (2008 to 2010) with Additional Assessment of Incidence and Prevalence

Scheer, Darren

March 2019

Background and Significance: Narcolepsy is a chronic neurological disorder. These patients experie...

Sub-group analysis comparing CV-disease incidence in patients with vs. without insomnia based on length of follow-up period.

Eman Ali (7497833)
Asim Shaikh (17020701)
Farah Yasmin (11744603)
Fatima Sughra (17020704)
Ayesha Sheikh (17020707)
Rabia Owais (17020710)
Hamna Raheel (17020713)
Hafeez Ul Hassan Virk (10743664)
Jihad A. Mustapha (9085634)

September 2023

Sub-group analysis comparing CV-disease incidence in patients with vs. without insomnia based on len...

Case-centered analysis results of Guillain-Barré syndrome (GBS) with prior vaccination and with prior infection, Vaccine Safety Datalink, 2009–2011.

Sharon K. Greene (427152)
Melisa D. Rett (368699)
Claudia Vellozzi (427153)
Lingling Li (427154)
Martin Kulldorff (57938)
S. Michael Marcy (427155)
Matthew F. Daley (427156)
Edward A. Belongia (209731)
Roger Baxter (427157)
Bruce H. Fireman (427158)
Michael L. Jackson (411527)
Saad B. Omer (199402)
James D. Nordin (427159)
Robert Jin (427160)
Eric S. Weintraub (427161)
Vinutha Vijayadeva (427162)
Grace M. Lee (427163)

June 2013

aAdjusted for GBS onset date, age group, sex, site, and medically-attended infection status in 1 ...

Retrospective multicenter matched case–control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany

Oberle, Doris
Pavel, Jutta
Mayer, Geert
Geisler, Peter
Keller-Stanislawski, Brigitte

January 2017

Objective: Studies associate pandemic influenza vaccination with narcolepsy. In Germany, a retrospec...

Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers

남궁기
이은

January 2015

BACKGROUND: Previous reports mostly from Europe suggested an association between an occurrence of na...

Case-only analysis investigating prescription (ATC) history during the vaccination period and before index date and diagnosis (ICD10) history before index date on risk of developing narcolepsy.

Abstract

Extracted data

Case-only analysis investigating prescription (ATC) history during the vaccination period and before index date and diagnosis (ICD10) history before index date on risk of developing narcolepsy.

Abstract

Extracted data

Related items

Related items